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Abstract
It has been suggested that atypical amygdala function contributes to the social impairments
characteristic of autism spectrum disorders (ASDs). Previous research has demonstrated that
adolescents and adults with ASD generate normal response during a fear-potentiated startle
paradigm, suggesting this aspect of amygdala function is intact and may not account for the social
dysfunction associated with the condition. The amygdala also plays a crucial role in the expression
of anxiety and may contribute to high rates of reported anxiety in individuals with ASD. The
present study partially replicates prior work by examining the fear-potentiated startle response in
adolescents with ASD, and extends this to investigate the relationship between startle response
and anxiety. Eyeblink magnitude and latency (electromyographic activity; EMG) were collected
from 20 adolescents with ASD and 19 typically developing (TD) age-matched adolescents during
a fear-potentiated startle paradigm. Parent report and self-report of anxiety and additional
psychiatric symptoms were collected. Parental reports indicated higher rates of associated
psychopathology in adolescents with ASD compared with TD adolescents. Consistent with
previous results, both groups showed normal potentiated startle response, and no group differences
in EMG were found. Symptoms of anxiety and level of social impairment were unrelated to startle
response. These findings held for all levels of anxiety, suggesting that within the context of the
fear-potentiated startle paradigm, amygdala response is not associated with degree of atypical
social or emotional functioning in ASD.
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With recent prevalence of autism spectrum disorders (ASDs) estimated at 1 in 88 youth in
the United States, there is growing public health concern for treating and managing the
clinical complexities associated with the condition [Autism and Developmental Disabilities
Monitoring Network Surveillance Year 2008 Principal Investigators & Centers for Disease
Control and Prevention, 2012]. In addition to the triad of core deficits, psychiatric
disturbances with ASD occur at very high rates [e.g. Gjevik, Eldevik, Fjæran-Granum, &
Sponheim, 2011]. Comorbid psychiatric symptoms, including anxiety, can be difficult to
detect in ASD because of difficulties with communication and lack of standardized
measures. Nevertheless, co-occurring anxiety disorders among children and adolescents with
ASD are increasingly recognized [e.g. van Steensel, Bögels, & Perrin, 2011].
ASD and Anxiety
Symptoms of anxiety may in fact be the most commonly associated psychiatric concern
among individuals with ASD [Skokauskas & Gallagher, 2010], with rates ranging from 40%
to 84% [e.g. de Bruin, Ferdinand, Meester, de Nijs, & Verheij, 2006; Muris, Steerneman,
Merckelbach, Holdrinet, & Meesters, 1998; van Steensel et al., 2011]. Systematic reviews
indicate higher rates of anxiety in older children [van Steensel et al., 2011; White, Oswald,
Ollendick, & Scahill, 2009], suggesting that adolescents may be at particularly high risk.
Anxiety symptoms can lead to significant functional impairment and exacerbation of core
ASD symptomology, or even be the most disabling feature of ASD [Seltzer, Shattuck,
Abbeduto, & Greenberg, 2004]. Evidence suggests that parental report of increased anxiety
is associated with a number of concerns including deficits in child self-esteem, academic
success, social skills, peer relationships, social responsiveness, and potential to be bullied
[Bellini, 2004; McPheeters, Davis, Navarre, & Scott, 2011; Reaven, 2009; Sukhodolsky et
al., 2008]. Comorbid anxiety is also associated with problem behavior (e.g. conduct,
learning, somatic, impulsivity, and hyperactivity) in youth with ASD [Evans, Canavera,
Kleinpeter, Maccubbin, & Taga, 2005]. Anxiety may intensify core ASD symptoms,
underscoring its clinical impact [Wood & Gadow, 2010].
Determining whether an individual with ASD has comorbid anxiety is challenging, given
that symptoms arising from both conditions lead to similar behavioral manifestations. For
example, social avoidance might be considered a symptom of social anxiety when attributed
to anxious anticipation or distress [American Psychiatric Association, 2000]. But in many
children with ASD, this behavior may simply reflect core deficits in social motivation or
skill. Although rigorous diagnostic criteria and standardized measures for ASD and anxiety
exist, in the absence of a reliable biological marker, diagnostic distinctions often depend on
clinical judgment. Moreover, research has yet to clarify whether anxiety symptoms have the
same clinical manifestation in ASD as they do in typically developing (TD) individuals.
High rates of comorbid anxiety are generally based on interviews and questionnaires
designed to assess anxiety in TD individuals, and have not yet been validated in the ASD
population. It is unclear the extent to which these methods are measuring the same construct.
One potential strategy to address this challenge is to investigate whether the underlying
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biological mechanisms associated with anxiety in ASD are analogous to mechanisms
observed in TD individuals.
The Amygdala and ASD
It has been hypothesized that the amygdala, which plays a major role in emotional response
to aversive stimuli [e.g. Adolphs & Tranel, 1999], influences social and emotional
functioning in ASD. This is due in part to the observation that experimental lesions of the
amygdala lead to a range of social-emotional impairments that resemble ASD. For example,
monkeys with Klüver–Bucy syndrome, resulting from bilateral lesions to the anterior
temporal lobes, exhibit lack of facial expression and absence of emotional reactions [Klüver
& Bucy, 1939]. Bilateral removal of the amygdala in newborn monkeys results in social
avoidance, disinterest, unexpressive faces, flattened vocalizations, and diminished eye
contact [Bachevalier, 1996; Newman & Bachevalier, 1997]. Similar to individuals with
ASD [Uono, Sato, & Toichi, 2011], postencephalic people with damage to the amygdala
show impaired recognition of facial expressions of fear [Broks et al., 1998].
In fact, there is evidence of atypical amygdala structure and function in ASD. Postmortem
studies have revealed possible microscopic amygdala abnormalities in ASD [e.g. Kemper &
Bauman, 1998], although findings are not consistent [Schumann & Amaral, 2006]. Findings
from imaging studies are also varied, with evidence suggesting that amygdala development
may be atypical in ASD. Specifically, the amygdala is initially larger in young children [e.g.
Sparks et al., 2002] but does not undergo the expected age-related increase in volume
observed in TD children; the result is that no differences in amygdala volume are found
between ASD and typical adolescents, despite the altered growth trajectory [e.g. Schumann
et al., 2004]. In toddlers with ASD, larger amygdala volume has been associated with
impaired social and communication skills and poorer outcome [Munson et al., 2006;
Schumann, Barnes, Lord, & Courchesne, 2009].
There are two divergent viewpoints regarding the specificity and consequences of amygdala
dysfunction in ASD. First, the “amygdala theory of autism” [Baron-Cohen et al., 2000]
suggests that the amygdala is one component of the “social brain,” which represents the
underlying neural substrates for social intelligence [Brothers, 1990]; thus, disruption of this
system would account for development and maintenance of social impairments in ASD.
Alternatively, findings from animal studies suggest that the amygdala may be responsible
for appropriate fear response, rather than social functioning [Amaral & Corbett, 2003]. For
example, amygdala-lesioned monkeys show decreased fear responses to previously aversive
stimuli [Weiskrantz, 1956], reduced cautiousness and inhibition when introduced to
unfamiliar monkeys [Emery et al., 2001], and more fear behavior such as grimaces, screams,
and general heightened sense of fear during dyadic social interactions [Prather et al., 2001].
These findings have led to the idea that the amygdala may contribute to the ability to detect
threats and mobilize an appropriate behavioral response; amygdala dysfunction in ASD
would therefore contribute to increased levels of fear and anxiety, rather than fundamentally
impacting social impairments [Amaral, Bauman, & Schumann, 2003]. Consistent with this
hypothesis, structural evidence from magnetic resonance imaging indicates that symptoms
of anxiety, but not cognitive ability or Autism Diagnostic Observation Schedule (ADOS)
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scores, are correlated with increased amygdala volume in children with ASD [Juranek et al.,
2006].
Amygdala and Anxiety
Hyperresponsivity within the amygdala to threat-inducing stimuli mediates physiological
symptoms of anxiety, such as autonomic hyperarousal [Rauch, Shin, & Wright, 2003]. As
expected, neuroimaging studies have revealed increased amygdala activation, or
hyperresponsivity, during anxiety provocation in individuals with social anxiety disorder,
specific phobias, and posttraumatic stress disorder (PTSD) [Fredrikson & Furmark, 2003;
Liberzon et al., 1999; Tillfors et al., 2001], supporting a neurocognitive model of underlying
amygdala dysfunction in anxiety disorders [e.g. Bishop, 2007].
The amygdala is crucially involved in both the acquisition and expression of fear
conditioning, making this process particularly informative in understanding amygdala
function [e.g. Wilensky, Schafe, Kristensen, & LeDoux, 2006]. In fact, humans with
amygdala damage exhibit fear conditioning impairment [Coopens, van Paesschen,
Vandenbulcke, & Vansteenwegen, 2010]. Fear conditioning can be assessed via a
noninvasive method known as startle response, elicited by a sudden onset of a stimulus.
Startle magnitude can be modified or enhanced by exposure to a conditioned stimulus (CS)
previously paired with an aversive unconditioned stimulus (US). The CS produces a state of
fear that potentiates the startle response and increases reflexive behavior. The fear-
potentiated startle (FPS) effect refers to the exaggerated startle reaction potentiated by the
learned CS–US association [see Lang, Davis, & Ohman, 2000 for a review]. In essence, the
threat cue primes an individual for response, creating a fear state, manifested by an
exaggerated startle reflex to any sudden new stimulus. This reflex is viewed as a defensive
response that varies with the individual’s emotional state [Lang, Bradley, & Cuthbert, 1990].
The startle response is characterized by a fast series of muscle contractions around the head,
neck, and shoulders; the eyeblink is the first, fastest, and most reliable part of this reaction
[Dawson, Schell, & Bohmelt, 1999]. Strength of the startle reflex is measured by
electromyographic (EMG) activity of the orbicularis muscle during the eyeblink, or blink
magnitude.
Potentiated startle response tends to be larger in individuals with higher levels of fear and
anxiety, [e.g. Grillon, Ameli, Foot, & Davis, 1993], perhaps reflecting a general startle
sensitivity in individuals with high “negative affect” and sustained anxious apprehension
and arousal [Lang et al., 2000]. Enhanced potentiated startle has been reported in individuals
with PTSD [e.g. Grillon & Morgan, 1999], social anxiety [Lissek et al., 2008; McTeague et
al., 2009], and specific phobias [Sabatinelli, Bradley, & Lang, 2001], and in youth with
anxiety disorders [Waters, Henry, & Neumann, 2009]. Larger startle responses have also
been reported in youth at risk for anxiety, suggesting that startle reactivity may serve as a
vulnerability marker for the development of anxiety [Grillon, Dierker, & Merikangas, 1997].
Startle is particularly potentiated by stimuli with negative valence, including aversive airpuff
[e.g. Grillon et al., 1999].
Few studies have utilized the startle paradigm to measure eyeblink magnitude with
individuals with ASD, despite strong implications for amygdala dysfunction in the disorder.
Sterling et al. Page 4






















Overall, findings indicate no differences in potentiated startle response compared with
control groups. There were no group differences in amplitude of startle response to a
conditioned acoustic probe found in 14 children and adolescents with high-functioning
autism, ages 8–18, and 18 age-gender-matched control children [Salmond, de Haan, Friston,
Gadian, & Vargha-Khadem, 2003]. Similarly, no differences were reported in 14
adolescents and adults with ASD, and 14 matched controls using an acoustic FPS [Bernier,
Dawson, Panagiotides, & Webb, 2005]. In sum, both studies conclude that ASD per se does
not appear to be associated with increased startle response.
The Current Study
This is the first study to use FPS to elucidate mechanisms of anxiety in addition to social
dysfunction in ASD. Startle response could potentially help identify a subset of individuals
with ASD with autonomic hyperarousal and propensity for developing anxiety. Adolescents
were the focus of the current study given increased risk for anxiety during this phase of
development [Kessler, Ruscio, Shear, & Wittchen, 2010], as well as specifically in youth
with ASD [e.g. Kuusikko et al., 2008]. The primary aims of the current study were to: (a)
determine whether a particular aspect of amygdala function, namely FPS, was impaired in
adolescents with ASD and related to social deficits, and (b) assess anxiety symptoms with
both child report and parent report, and examining the relationship between anxiety and
FPS. Based on normal FPS reported in previous studies, together with the age-related pattern
of amygdala function described earlier, it was hypothesized that both adolescents with ASD
and TD would exhibit normal FPS response, and as such, FPS response would not be
associated with social impairment in ASD. Moreover, it was hypothesized that if manifest
anxiety symptoms in individuals with ASD represent the same construct as anxiety in TD,
FPS would increase as a function of anxiety severity. If a positive relationship between
anxiety and FPS was not found among adolescents with ASD, this would suggest different
physiological mechanisms contributing to anxiety, or symptoms that appear on the surface to




Recruitment took place through an ongoing longitudinal study at the University of
Washington (UW) Autism Center, yielding 11 participants with ASD and ten TD
participants. Additionally, nine adolescents with ASD and ten TD adolescents were recruited
through the UW Autism Center, as well as a local network of medical practices and parent
advocacy groups and the UW Communications Subject Pool. Because of equipment error
during the FPS experiment, data for one TD teen were not included in the final analyses. All
aspects of the study, including recruitment, were approved by the UW Institutional Review
Board.
The final sample consisted of 20 high-functioning adolescents with ASD (autistic disorder, n
= 8; Asperger’ s disorder, n = 9; pervasive developmental disorder not otherwise specified
[PDD-NOS], n = 3) and 19 TD adolescents. Adolescents in the TD group were matched on
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chronological age to the teens with ASD; all participants were between 13 and 17.5 years of
age at the time of assessment (see Table 1 for sample characteristics). Minority
representation reflected the distribution of the greater Seattle area, with 20.5% of teens in
the total sample being nonwhite. There were three females in the ASD group and six in the
TD group.
Exclusionary criteria included neurological disorder of known etiology, significant sensory
or motor impairment, major physical abnormalities, birth prematurity, alcohol or drug
exposure during the prenatal period, and history of serious head injury and/or neurological
disease. In addition, adolescents in the TD group were excluded if there was a family history
of ASD, birth or developmental abnormalities, learning or language disability, and current or
past history of psychiatric or neurological disorders or that required regular psychoactive
medication. Exclusionary criteria were assessed via administration of an initial phone
screening, which included administration of the Vineland Adaptive Behavior Scales
[Sparrow, Balla, Cicchetti, & Doll, 1984], to ensure that TD individuals were not
significantly delayed in adaptive functioning. Teens were also assessed to ensure adequate
verbal skills (see cognitive assessment later).
Inclusion criteria included confirmation of an ASD. Participants recruited through the
longitudinal study met criteria for an ASD at their first visit (age 3 years) by exceeding
cutoffs on the Autism Diagnostic Interview-Revised (ADI-R) and ADOS, and through
clinical judgment based on Diagnostic and Statistical Manual of Mental Disorders, Fourth
Edition (DSM-IV) criteria. Newly recruited participants were diagnosed with an ASD using
the ADI-R and ADOS, and clinical judgment based on DSM-IV criteria. All participants in
the current study were administered a cognitive assessment (see later) and were required to
have a full scale intelligence quotient (IQ) of at least 80.
Measures
Cognitive assessment—IQ was assessed using the Differential Ability Scales, 2nd
Edition [DAS-II; Elliott, 2007] at the first visit. Clinical judgment was also used to ensure
that participants demonstrated adequate receptive and expressive language abilities to
participate in the study, as self-report of psychiatric symptoms and participation in the startle
paradigm required adequate verbal and written abilities. Table 1 presents scores for both
groups. On average, the TD group yielded significantly higher Differential Ability Scales
General Conceptual Ability standard scores (t(37) = −4.37, P < 0.001), Verbal Cluster
standard scores (t(37) = −3.58, P = 0.001), Nonverbal Cluster standard scores (t(37) =
−2.94, P = 0.006), and Spatial Cluster standard scores (t(37) = −3.92, P < 0.001) than the
ASD group.
Diagnostic assessment—Diagnosis of an ASD (autistic disorder, Asperger’s disorder,
or PDD-NOS) was based on the ADI-R [Lord, Rutter, & Le Couteur, 1994] and the ADOS-
WPS [Lord, Rutter, DiLavore, & Risi, 2002]. In addition, expert clinical judgment of
diagnosis was made according to DSM-IV diagnostic criteria.
Child report of psychiatric symptoms was assessed during the second visit. Anxiety was
measured using the Revised Children’s Manifest Anxiety Scale Second Edition [RCMAS-2;
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Reynolds & Richmond, 1997], designed to measure anxiety in youth 6–19 years of age. The
measure comprises 37 yes/no questions and provides scores for Total Anxiety as well as
four subscales: worry/oversensitivity, physiological anxiety, social concerns/concentration,
and lie (defensiveness) scale. Depression was assessed using the Reynolds Adolescent
Depression Inventory, Second Edition [RADS-2; Reynolds, 1987], which evaluates the
current level of an adolescent’s depressive symptomatology along four basic dimensions of
depression: dysphoric mood, anhedonia/negative affect, negative self-evaluation, and
somatic complaints, as well as yielding a depression total score representing overall
depressive severity.
In order to decrease potential anxiety associated with completing written questionnaires
administered by the examiner, the RCMAS-2 and RADS-2 were formatted for use on a
laptop computer. All participants utilized the computer to indicate their answers.
Parent report of psychiatric symptoms was assessed using the Child Behavior Checklist
[CBCL; Achenbach & Rescorla, 2001]. The CBCL consists of 118 items measuring total
behavior problems, broad-band behavior problems (e.g. internalizing behavior problems,
externalizing behavior problems), and narrow-band behavior problems (e.g. anxious/
depressed, withdrawn/depressed, somatic complaints, social problems, thought problems,
attention problems, rule-breaking behavior, and aggressive behavior). For the purposes of
the current study, only scores on the internalizing domain and the subscales composing the
internalizing domain (i.e. anxious/depressed, withdrawn/depressed, and somatic complaints)
are included.
Parent report of social functioning—The Social Skills Rating System [SSRS;
Gresham & Elliott, 1990] assesses social competence in terms of cooperation, assertion,
responsibility, and self-control using parent report. Based on these subscales, standard
scores are created encompassing two scales: social skills and problem behavior. The Social
Responsiveness Scale [SRS; Constantino et al., 2003] is a 65-item rating scale of the
severity of ASD symptoms, specifically related to social impairment. The SRS yields a total
score of ASD impairment and subscale scores based on items assessing social awareness,
social cognition/information processing, capacity for reciprocal social responses, social
motivation, and autistic mannerisms. Scores on the SRS tend to correspond with the ADI
[Constantino et al., 2003].
FPS
Assessment of the FPS experiment took place on the second visit in the UW Integrated
Brain Imaging Center. At the first visit, the option for training was provided to familiarize
adolescents with the testing room and equipment.
The following procedures are adapted from those described by Bernier et al., [2005].
Participants sat in a comfortable chair facing a blank computer screen and were instructed
that they would see different colors appear on the computer screen, hear a startling noise
over the headphones, and periodically feel an airpuff from the plastic tubing draped over
their neck. The paradigm consisted of four phases: habituation I, conditioning, habituation
II, and testing. In order to reduce initial reactivity, the habituation phase began with a single
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airpuff followed by 12 acoustic startle probes presented between 13 and 19 sec apart, while
participants viewed a blank white computer screen. The conditioning phase followed; the CS
(a red-colored square) appeared for 2,000 msec on the computer screen. Presentation of the
aversive US (the aversive airpuff) overlapped for 50 msec and terminated simultaneously
with the CS. Participants received 20 pairs of the CS and the US to facilitate learning of the
CS–US association. The conditioning phase was followed by a second habituation phase,
consisting of five presentations of the acoustic startle stimulus (SS) alone. Finally, the
testing phase consisted of 30 trials presented in randomized order so that participants could
not anticipate the next stimulus. Six trials consisted of the CS–US pairing to maintain
conditioning. Twelve trials consisted of the CS–SS. These trials served as the “threat
condition,” during which the CS was expected to potentiate response to the SS. In the threat
condition, the SS was presented after 1,000 msec of the CS onset (i.e. when the participant
was most likely in a potentiated state), which lasted for 2,000 msec. The other 12 trials
consisted of the SS alone, comprising the “safe” condition (see Fig. 1).
Stimuli
The US (airpuff) consisted of a burst of air directed at the throat through a 4-mm internal
diameter polyethylene tubing, with 200 msec duration and a pressure of 60 psi. Activation of
the airpuff was controlled via a solenoid powered by an AC switch, electronically regulated
by Eprime software (••, ••, ••). Compressed air was stored in a cylinder, which was
connected to the solenoid using plastic tubing that passes through a regulator. The acoustic
SS consisted of a 50-msec burst of white noise presented to both ears through headphones at
100 decibels. Visual and auditory stimuli were presented via Eprime on a data presentation
computer.
Data Recording and Preparation
Consistent with procedures outlined in Bernier’s [[2005] published study and following
recommendations for electrode placement from Fridlund and Cacioppo [1986], EMG
activity was recorded using two Ag/AgCl surface electrodes placed under the left eye
(orbicularis oculi) with a ground electrode placed on the forehead. Electrodes were affixed
using EC 2 Electrode Cream (••, ••, ••). Placement of electrodes took approximately 10 min
for each participant. A Biopac system (Goleta, CA, USA) recorded eyeblink latency and
magnitude via the EMG electrodes. Intensity of EMG response was determined in the 20–
100 msec following stimulus presentation. Although EMG activity was recorded
continuously throughout the experiment, for the purpose of analyses, the responses in the
testing phase were of interest. Specifically, the 12 responses to the “threat” and 12 responses
to the “safe” conditions were representative of the FPS effect, providing 12 “time points” for
each of the two conditions. Theoretically, responses to the “threat” condition should be
larger than those to the “safe” if conditioning was successful. Prior to analysis (described in
more detail later), the time variable for the EMG measurements reflected the time when the
first stimulus was presented as zero. Thus, the first “threat” (e.g. “threat” 1) or “safe”
stimulus time was set to zero to create a centered stimulus time.
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According to child report, groups did not differ in terms of symptoms of anxiety. However,
the adolescents with ASD reported significantly higher levels of total depression than
adolescents in the TD group, with significantly more reported symptoms within the domains
of dysphoric mood, anhedonia/negative affect, negative self-evaluation, and somatic
complaints. See Table 2 for a summary of RCMAS-2 and RADS-2 scores for each group.
Parents of teens with ASD reported significantly more symptoms and behaviors related to
internalizing symptoms (internalizing domain; anxious/depressed, withdrawn/depressed
subscales) than parents of TD teens. Parent report of psychiatric symptoms using the CBCL
is reported in Table 3.
Social Skills
Parents of adolescents with ASD reported significantly more social impairment on the SRS
and SSRS than parents of TD adolescents. Results from these parent measures of social
skills are presented in Table 3.
FPS Response
A linear mixed model was conducted to compare the maximum amplitude of the startle
response (EMG) for each condition (threat, safe). As illustrated in Figure 2, both groups
exhibited significantly greater startle magnitude for the threat versus the safe condition
(t(893) = 5.80, P < 0.001). No differences in magnitude were found between groups,
indicating that both groups demonstrated potentiated response during the threat condition,
but did not differ from each other in terms of mean amplitude of EMG response.
Latency of startle response was also examined using a linear mixed model (see Fig. 3). Both
groups exhibited shorter latency (i.e. faster response) to the threat condition versus the safe
condition, (t(893) = −2.40, P < 0.05), but did not differ from each other in terms of latency
of response.
Next, the relationship between parent- (CBCL) and child-reported (RCMAS) anxiety and
FPS, and parent-rated social skills (SSRS, SRS) and FPS were examined for the ASD group.
No significant correlations emerged between the CBCL internalizing domain, the associated
subscales that comprise the internalizing domain (anxiety/depressed, withdrawn/depressed,
and somatic complaints), RCMAS subscales or total score, SSRS sub-scales and total score,
SRS subscales and total score, and EMG amplitude during the threat condition (rs = −0.18
to 0.30, ps > 0.19). The same correlations were conducted between measures of anxiety and
social skills and EMG latency of response for the ASD group; there were no significant
relationships (rs = −0.46 to 0.32, ps > 0.13, with the exception of problem behavior, P =
0.062). In light of high rates of reported depression discussed earlier, for exploratory
purposes, we examined the correlations between depressive symptoms (RADS-2) and EMG
amplitude and latency; no significant correlations were revealed (rs = −0.39 to 0.37, ps >
0.11).
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Consistent with previous findings [e.g. Mazurek & Kanne, 2010], teens with ASD exhibited
more symptoms associated with internalizing conditions compared with their TD peers,
based on both parent and child report. This was especially evident in ASD teens’ self-report
of depressive symptoms on the RADS-2, which revealed significant elevations across all
domains compared with TD teens. Contrary to expectations, adolescents with ASD did not
report more symptoms of anxiety than their TD peers. On the other hand, parents of teens
with ASD reported greater overall symptom severity across all internalizing domains of the
CBCL (anxious/depressed, withdrawn/depressed, and somatic) compared with parents of TD
teens.
It is important to note that although adolescents with ASD self-reported significantly higher
levels of depression than the TD group based on the RADS-2, the only scale that was
actually elevated within the ASD group was total depression (t-score = 60.11). For all other
scales, the t-scores fell close to the population mean of 50. However, ASD scores were
relatively elevated compared with the average t-scores for the TD group, which fell below
the mean, ranging from 41.17 to 43.33.
With regard to the RCMAS-2, the adolescents with ASD did not report more symptoms of
anxiety than their TD peers. However, the scores for the ASD group converge around 1
standard deviation above the population mean, suggesting mild, subclinical anxiety in the
group. Interestingly, the TD group reported symptoms 1–1.5 standard deviations above the
population mean as well, suggesting the TD group may also be exhibiting subclinical levels
of anxiety. The parents of the TD group did not report elevated anxiety in their children,
suggesting that TD teens in this study may be exhibiting underlying internalizing symptoms
not apparent to their caregivers. It is also possible that the startle session itself elicited
anxiety, which could be reflected in the self-report measures completed during this visit.
This may have been more salient for the TD versus ASD group, given that many of the
participants in the ASD group had prior experience with a variety of psychophysiology
measures at the laboratory.
Parent and child report of psychiatric symptoms did not correspond with each other.
Previous findings suggest that an association between adult and child ratings of internalizing
symptoms is often low because adults do not have access to the internalizing experiences of
the children [Achenbach, McConaughy, & Howell, 1987]. Within ASD, evidence suggests
elevated rates of depression and anxiety in children with ASD when assessed via parent, but
not child, report; child report of depression has been shown to correlate with parent report of
depression, whereas measures of anxiety do not [Lopata et al., 2010]. Results from the
current study support this pattern of findings. Elevated CBCL but not RCMAS-2 scores may
be a reflection of more accurate report of anxiety symptoms by parents versus children with
ASD. Examination of individual items on the CBCL suggests parents of adolescents with
ASD endorsed symptoms related to anxiety at higher rates than parents of adolescents with
TD (e.g. fears he/she might do something bad; nervous, high strung, or tense; too fearful or
anxious), suggesting that anxiety may be present in this sample of teens with ASD, but not
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detected using self-report. Alternatively, parents may misinterpret behavioral manifestations
of core ASD symptoms as anxiety, thereby inflating CBCL scores.
Moreover, consistent with present findings, Lopata et al. [2010] found that depression was
more prominent than anxiety in their sample of 40 children with ASD. The correspondence
between child and parent report may be an indication that depressive symptoms are more
common in youth with ASD, or more easily detected and better understood by children and
their parents. Behaviors and emotions indicative of anxiety may be more difficult to
recognize and interpret given their overlap with ASD core symptoms or their variable and
atypical expression in ASD. In addition, although the current sample was expected to exhibit
high levels of anxiety based on rates previously reported in the literature, this sample was
not recruited specifically for clinical anxiety, thereby reducing the overall anxiety
symptomatology and variability within the group; the size of the ASD sample may also
contribute to these limitations.
The current study utilized child report as a primary anxiety measure, whereas previous
studies yielding high rates tended to rely on parent report [e.g. Sukhodolksy et al., 2007].
Lack of insight and ability to recognize and report emotional states and mood fluctuations
may have contributed to inaccurate report of anxiety by teens with ASD [Hill, Berthoz, &
Frith, 2004]. The fact that adolescents in the study were able to recognize and report their
depressive symptoms may challenge this notion; however, the interpretation of anxiety may
be reliant on a more sophisticated cognitive process and thus more difficult to recognize
than depression [e.g. Beck & Clark, 1988]. This is consistent with previous reports
suggesting that higher functioning individuals with ASD are capable of self-report of
depressive symptoms [Berthoz & Hill, 2005].
Finally, the RCMAS-2 and CBCL are not validated for use with individuals with ASD. The
CBCL has previously yielded elevated rates in large samples of youth with ASD, which may
actually be driven by the core impairments of ASD itself rather than comorbid symptoms
[e.g. Mazefsky, Anderson, Conner, & Minshew, 2011]. Such findings call into question the
utility of this measure in identifying and quantifying coexisting psychopathology in ASD.
The lack of validated assessments is especially noteworthy given that clinical observation
indicated that several of the teens had significant symptoms of anxiety, requiring
accommodations during the assessments (e.g. requiring frequent explanations of what to
expect, and familiarization with the psychophysiology materials and settings before
commencing with tasks). Granted, these needs could be conceptualized as reflections of
autism symptoms (e.g. need for routine and difficulty transitioning), yet one would still
expect that such behaviors would be identified by measures of anxiety. A more in-depth
diagnostic interview for anxiety may have been informative, but this was not feasible given
the limitations of the current study. Lack of a clinically validated measure of anxiety
provides further incentive for identification of a biomarker for such symptoms.
Consistent with previous results, the present study demonstrated that adolescents with ASD
and TD potentiated the startle response, as demonstrated by larger EMG magnitude and
faster response to the threat condition. Further, there were no group differences in magnitude
or latency of the EMG startle response. Within the ASD group, parent-reported social
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functioning and parent- and self-reported symptoms of anxiety were not related to EMG
magnitude or latency.
A discussion of the ASD and TD sample features is worth including, given the potential for
individual characteristics to impact startle response. For example, the TD group is composed
of three additional females than the ASD group. Evidence suggests that there are sex
differences in eyeblink conditioning; in particular, females may learn to elicit the eyeblink
response sooner than males, perhaps because they are anticipating the onset of the US [Dalla
& Shors, 2009]. It is conceivable that the startle magnitude was inflated or the latency was
reduced in the TD group, given the three additional females. These sex differences appear to
emerge after puberty [Dalla & Shors, 2009], and puberty status was not available on the
current sample. The TD group also exhibits higher average cognitive scores (mean = 126.84)
than the ASD group (mean = 104.60), as measured by the DAS. The impact of IQ is
expected to be negligible given that fear circuitry depends on primary sensory systems rather
than more complex structures supporting language or multi-faceted social behavior, and
does not require reportable perception of the fear-eliciting stimulus [e.g. Lang et al., 2000].
In fact, this reliance on more basic systems makes startle response ideal for use with
populations with limited communication, providing a nonverbal indication of underlying
neural mechanisms contributing to pathology.
These results suggest that within the context of the FPS paradigm, amygdala function is
intact in adolescents with ASD. Despite a large body of evidence implicating amygdala
dysfunction in ASD, participants in the current study were able to acquire the conditioning
(i.e. the CS–US association), evidenced by heightened response to the threat condition. The
formation of the CS–US association is thought to take place in the basal and lateral nuclei of
the amygdala, with the central nucleus projecting to various autonomic and somatomotor
networks involved in mediating the fear response [see Kim & Jung, 2006 for review].
Findings from the present study suggest that social symptoms associated with ASD, assessed
using the SRS and SRSS, are not linked directly to these components of amygdala function,
at least as measured by FPS. It is reasonable to hypothesize that symptoms of ASD may be
related to the functions of other amygdala nuclei not measured by FPS.
The lack of association between symptoms of anxiety and EMG response among the teens
with ASD contradicts the pattern reported in the TD literature of larger startle response
associated with greater anxiety symptomology. For example, in a study of over 100
adolescents, participants with high levels of behavioral inhibition and a lifetime occurrence
of anxiety disorders exhibited increased startle reactivity, suggesting that this reflex could
actually be a vulnerability marker for the development of anxiety in teens [Reeb-Sutherland
et al., 2009]. There are several possible explanations for the absence of a significant
relationship in the current sample of adolescents. First, it is possible that symptoms that
appear on the surface as manifest anxiety are not actually tied to the same physiological
underpinnings as those linked to true clinical anxiety. Parents and teens used measures
(RCMAS-2, CBCL) that were validated for the evaluation of psychopathology in the TD
population. It is conceivable that the reported anxiety symptoms among the teens with ASD
in this study are reflections of other behaviors or symptoms related to ASD. As such,
physiological mechanisms that represent anxiety would not be detected. It is also possible
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that individuals with ASD experience atypical symptoms of anxiety that are not mediated by
the same underlying physiological processes as those observed in TD individuals. The lack
of validated measures of comorbidity in ASD constrains proper interpretation of reported
symptoms, limiting their utility in detecting a relationship with physiological mechanisms.
Second, while a few parents reported clinical levels of anxiety in their child with ASD, this
sample generally had limited variability in symptoms, making it difficult to examine the
relationship between varying levels of anxiety and physiological response; recruiting
specifically for individuals with ASD who have known difficulties with anxiety may help
address this issue for future studies. Third, there may have been insufficient power to detect
a relationship between anxiety and EMG response given the relatively small sample size of
20 adolescents with ASD. Future research would benefit from exploring the association
between anxiety and physiological response in larger groups of individuals with ASD to
confirm whether this was a limiting factor for the current study. Finally, self-report indicated
that the current sample of teens with ASD suffered from significant depression. Depression
and anxiety are difficult to tease apart and rarely occur as distinctly unique conditions
among adolescents [e.g. van Lang, Ferdinand, Ormel, & Verhulst, 2006]; this makes
interpretation of findings, particularly the relationship between anxiety and EMG, difficult.
In light of these challenges, the development of a standardized and validated tool for
measuring anxiety (and depression) in ASD would facilitate proper assessment of
symptoms, elucidation of biological mechanisms, and provision of appropriate treatment;
this should be an imminent focus of future work.
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Fear-potentiated startle paradigm [adapted from Bernier et al., 2005]. ITI, intertrial interval;
CS, conditioned stimulus; US, unconditioned stimulus.
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Mean of maximum electromyographic (EMG) amplitude for safe and threat conditions for
autism spectrum disorder (ASD) (n = 20) and typical (n = 19) groups.
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Mean latency of electromyographic (EMG) response for safe and threat conditions for
autism spectrum disorder (ASD) (n = 20) and typical (n = 19) groups.
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Table 2
Child report of anxiety and depression
ASD Typical
t-valueMean (SD) Mean (SD)
RCMAS-2 n = 20 n = 18
 Total anxiety 60.65 (11.17) 65.06 (11.24) −1.21
 Worry/oversensitivity 58.55 (9.37) 61.22 (12.59) −0.75
 Physiological anxiety 60.75 (13.42) 64.83 (9.17) −1.08
 Social concerns/concentration 58.45 (10.06) 64.33 (10.19) −1.79
RADS-2 n = 18 n = 18
 Total depression 60.11 (7.21) 50.89 (5.30) 4.37***
 Dysphoric mood 53.61 (8.93) 41.17 (6.82) 4.70***
 Anhedonia/negative affect 48.67 (7.05) 43.33 (5.24) 2.58*
 Negative self-evaluation 51.33 (11.44) 42.94 (4.30) 2.91**
 Somatic complaints 51.72 (7.28) 42.33 (9.80) 3.26**







ASD, autism spectrum disorder; SD, standard deviation; RCMAS-2, Revised Children’s Manifest Anxiety Scale Second Edition; RADS-2,
Reynolds Adolescent Depression Inventory, Second Edition.
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Table 3
Parent report of psychiatric symptoms and social functioning
ASD Typical
t-valueMean (SD) Mean (SD)
CBCL n = 19 n = 18
 Internalizing T 59.89 (7.62) 40.28 (6.92) 8.19***
 I. Anxious/depressed T 58.68 (8.17) 50.50 (1.65) 4.17***
 II. Withdrawn/depressed T 60.26 (8.75) 50.61 (1.29) 4.63***
 III. Somatic complaints T 58.26 (6.62) 52.11 (3.38) 3.53**
SSRS n = 17 n = 18
 Social skills 11.53 (3.81) 16.78 (3.06) −4.51***
 Problem behavior 5.41 (2.40) 1.89 (1.28) 5.46***
SRS n = 18 n = 16
 Total score 77.17 (10.67) 41.25 (6.79) 11.54***
 Social awareness 70.72 (10.54) 44.50 (11.41) 6.97***
 Social cognition 72.33 (9.71) 40.62 (7.12) 10.74***
 Reciprocal social communication 76.50 (12.78) 41.62 (6.72) 9.77***
 Social motivation 67.72 (11.78) 44.62 (6.97) 6.84***
 Autistic mannerisms 77.06 (10.83) 42.75 (4.17) 11.89***







ASD, autism spectrum disorder; SD, standard deviation; CBCL, Child Behavior Checklist; SSRS, Social Skills Rating System; SRS, Social
Responsiveness Scale.
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